MedPath
HSA Approval

APO-SULFATRIM PEDIATRIC TABLET

SIN00508P

APO-SULFATRIM PEDIATRIC TABLET

APO-SULFATRIM PEDIATRIC TABLET

April 28, 1988

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01EE02

sulfadiazine and trimethoprim

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

TRIMETHOPRIM

20 mg

Trimethoprim

SULPHAMETHOXAZOLE

100 mg

Sulfamethoxazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-SULFATRIM PEDIATRIC TABLET - HSA Approval | MedPath